
Diseases like rheumatoid arthritis and cancer affect millions every year, and our studies could help alleviate human suffering by identifying new drugs.

Our lab uses kinetic and structural analyses to guide the design of small molecule inhibitors, which we then synthesize and evaluate as inhibitors.
Fuhrmann, J., Clancy, K., Thompson, P.R.
(2015) Rev. 115 , 5413-5461. PMC4463550
this links to a paper called Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation
Humphries, F., Shmuel-Galia, L., Jiang, Z., Zhou, J., Barasa, L., Mondal, S., Wilson, R, Sultana, N., Shaffer, S.A., Ng, S., Pesiridis, G.S., Thompson, P.R.* and Fitzgerald, K.A. *
(2023) Targeting STING oligomerization with small-molecule inhibitors. PNAS 120, e2305420120.
this links to a paper called Targeting STING oligomerization with small-molecule inhibitorsMondal, S., Chen, Y., Lockbaum, G.J., Sen, S., Chaudhuri, S. Reyes, A.C., Lee, J.M., Kaur, A.N., Sultana, N. Cameron, M.D., Shaffer, S.A., Schiffer, C.A., Fitzgerald, K.A., and Thompson, P.R.
(2022) J. Am Chem Soc. 144, 21305-21045. PMID: 36356199. PMC9662648
this links to a paper called Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2Mondal, S., Wang, S., Zheng, Y., Sen, S., Chatterjee, A., and Thompson, P. R.
(2021) Nature Comm. 12, 45. PMID: 33398026
this links to a paper called Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2